Follow
Pawel Namsolleck
Pawel Namsolleck
PCDA Pharma Consulting & Data Analytics
Verified email at pcandda.com
Title
Cited by
Cited by
Year
Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease
SJ Ott, NE El Mokhtari, M Musfeldt, S Hellmig, S Freitag, A Rehman, ...
Circulation 113 (7), 929-937, 2006
4532006
Colonic microbiota signatures across five northern European countries
C Lay, L Rigottier-Gois, K Holmstrøm, M Rajilic, EE Vaughan, WM de Vos, ...
Applied and environmental microbiology 71 (7), 4153-4155, 2005
3422005
Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?
E Kaschina, A Grzesiak, J Li, A Foryst-Ludwig, M Timm, F Rompe, ...
Circulation 118 (24), 2523-2532, 2008
3172008
Impact of cereal fibre on glucose-regulating factors
MO Weickert, M Mohlig, C Koebnick, JJ Holst, P Namsolleck, M Ristow, ...
Diabetologia 48, 2343-2353, 2005
2512005
The β-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke
C Thöne-Reineke, C Neumann, P Namsolleck, K Schmerbach, M Krikov, ...
Journal of hypertension 26 (12), 2426-2435, 2008
1332008
The past, present and future of angiotensin II type 2 receptor stimulation
UM Steckelings, F Rompe, E Kaschina, P Namsolleck, A Grzesiak, ...
Journal of the Renin-Angiotensin-Aldosterone System 11 (1), 67-73, 2010
1252010
Non-peptide AT2-receptor agonists
UM Steckelings, M Larhed, A Hallberg, RE Widdop, ES Jones, ...
Current opinion in pharmacology 11 (2), 187-192, 2011
1242011
AT2 Receptor and Tissue Injury: Therapeutic Implications
P Namsolleck, C Recarti, S Foulquier, UM Steckelings, T Unger
Current hypertension reports 16, 1-10, 2014
1202014
AT2 receptors in cardiovascular and renal diseases
E Kaschina, P Namsolleck, T Unger
Pharmacological research 125, 39-47, 2017
1152017
AT2 receptor agonists: hypertension and beyond
UM Steckelings, L Paulis, P Namsolleck, T Unger
Current opinion in nephrology and hypertension 21 (2), 142-146, 2012
1092012
Evidence for heterodimerization and functional interaction of the angiotensin type 2 receptor and the receptor MAS
J Leonhardt, DC Villela, A Teichmann, LM Münter, MC Mayer, M Mardahl, ...
Hypertension 69 (6), 1128-1135, 2017
1072017
AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression
P Namsolleck, F Boato, K Schwengel, L Paulis, KS Matho, N Geurts, ...
Neurobiology of disease 51, 177-191, 2013
922013
Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis
R Winkler, V Benz, M Clemenz, M Bloch, A Foryst-Ludwig, S Wardat, ...
Diabetes 61 (2), 513-523, 2012
862012
Aldosterone synthase inhibitors in cardiovascular and renal diseases
P Namsolleck, T Unger
Nephrology Dialysis Transplantation 29 (suppl_1), i62-i68, 2014
592014
Molecular methods for the analysis of gut microbiota
P Namsolleck, R Thiel, P Lawson, K Holmstrøm, M Rajilic, EE Vaughan, ...
Microbial ecology in health and disease 16 (2-3), 71-85, 2004
532004
Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice
K Schwengel, P Namsolleck, K Lucht, BH Clausen, KL Lambertsen, ...
Journal of Molecular Medicine 94, 957-966, 2016
502016
Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune …
V Valero-Esquitino, K Lucht, P Namsolleck, F Monnet-Tschudi, T Stubbe, ...
Clinical science 128 (2), 95-109, 2015
452015
Hypertension-induced cognitive impairment: insights from prolonged angiotensin II infusion in mice
S Foulquier, P Namsolleck, BT Van Hagen, I Milanova, MJ Post, ...
Hypertension Research 41 (10), 817-827, 2018
442018
Clostridium asparagiforme sp. nov., isolated from a human faecal sample
R Mohan, P Namsolleck, PA Lawson, M Osterhoff, MD Collins, CA Alpert, ...
Systematic and applied microbiology 29 (4), 292-299, 2006
402006
Combined angiotensin receptor modulation in the management of cardio-metabolic disorders
L Paulis, S Foulquier, P Namsolleck, C Recarti, UM Steckelings, T Unger
Drugs 76, 1-12, 2016
372016
The system can't perform the operation now. Try again later.
Articles 1–20